Controversial results have also been reported for the association of Bcl-2 expression in R-CHOP-treated cohorts; in general, Bcl-2 expression influences the relative risk in OS in Bcl-6+ DLBCL but not in the Bcl-6− cases [37]. Here, BCL2 is linked to diffuse large B-cell lymphoma.